Back

CRE mice exhibit hyperactive and impulsive behavior affecting their learning and retention performances

Desor, F.; El Hajj, A.; Herzine, A.; Djelti, F.; Bombail, V.; Denis, I.; Oster, T.; Lanhers, M.-C.; Malaplate, C.; Yen, F. T.; Claudepierre, T.

2024-02-28 animal behavior and cognition
10.1101/2024.02.27.582228 bioRxiv
Show abstract

CRE recombinase is a protein that recognizes and mediates site-specific recombination between loxP site sequences. The Cre/loxP recombination system has become a useful tool for genetic manipulation. Spatial regulation of recombination can be achieved by using cell type-specific promoters that drive expression of CRE in the tissue of interest. The temporal regulation can be obtained with CreER recombinase, which consists of Cre fused to mutated hormone-binding domain of the estrogen receptor (ER). In the more improved versions of the construct, the CRE-mediated gene regulation can be controlled both spatially and temporally, by combining tissue-specific expression of a CreER recombinase with its tamoxifen-dependent activity. We recently generated and characterized an astrocyte specific mutant of the lipolysis-stimulated lipoprotein receptor lsr gene by crossing Glast ERT2 mice with floxed lsr mice (El Hajj et al., 2022). During the behavioral analysis of generated mice, we identified specific hyperactive traits in the Glast ERT2 mice (CRE mice) that prevented them from being used as a control group. Here we further assessed the hyperactive trait of those CRE mice using a battery of behavioral tests. We showed that CRE mice exhibited hyperactive behavior combined with attention-deficit, sleep disturbance and impulsivity that affect their learning and memorization performances. These mice may therefore serve as a model to study attention deficit / hyperactivity disorder. Our work also pointed out the need for proper behavioral analysis of control groups in transgenic animal generation to avoid misinterpretation and misattribution of behavioral traits.

Matching journals

The top 8 journals account for 50% of the predicted probability mass.

1
Scientific Reports
3102 papers in training set
Top 6%
10.2%
2
Biomedicines
66 papers in training set
Top 0.1%
10.2%
3
PLOS ONE
4510 papers in training set
Top 18%
10.2%
4
Frontiers in Neuroscience
223 papers in training set
Top 0.4%
6.4%
5
Neuroscience Letters
28 papers in training set
Top 0.1%
3.7%
6
Biology Open
130 papers in training set
Top 0.3%
3.6%
7
Behavioural Brain Research
70 papers in training set
Top 0.2%
3.6%
8
Translational Psychiatry
219 papers in training set
Top 2%
2.9%
50% of probability mass above
9
Experimental Brain Research
46 papers in training set
Top 0.2%
2.8%
10
Brain and Behavior
37 papers in training set
Top 0.2%
2.8%
11
Biology of Sex Differences
29 papers in training set
Top 0.2%
1.9%
12
Journal of Neurodevelopmental Disorders
15 papers in training set
Top 0.2%
1.9%
13
European Journal of Pharmacology
11 papers in training set
Top 0.1%
1.9%
14
iScience
1063 papers in training set
Top 11%
1.9%
15
Biology
43 papers in training set
Top 0.8%
1.7%
16
eLife
5422 papers in training set
Top 42%
1.7%
17
eneuro
389 papers in training set
Top 6%
1.5%
18
European Journal of Neuroscience
168 papers in training set
Top 0.8%
1.2%
19
Progress in Neuro-Psychopharmacology and Biological Psychiatry
36 papers in training set
Top 0.6%
1.2%
20
Journal of Cerebral Blood Flow & Metabolism
43 papers in training set
Top 0.5%
1.0%
21
Frontiers in Behavioral Neuroscience
46 papers in training set
Top 0.8%
0.9%
22
Heliyon
146 papers in training set
Top 5%
0.9%
23
Life Sciences
25 papers in training set
Top 1%
0.8%
24
Neurobiology of Disease
134 papers in training set
Top 4%
0.8%
25
Journal of Alzheimer’s Disease
39 papers in training set
Top 1%
0.7%
26
Genes
126 papers in training set
Top 4%
0.6%
27
Experimental Neurology
57 papers in training set
Top 2%
0.6%
28
Cells
232 papers in training set
Top 8%
0.6%
29
Neurobiology of Aging
95 papers in training set
Top 2%
0.6%
30
International Journal of Neuropsychopharmacology
11 papers in training set
Top 0.4%
0.5%